Human mesenchymal stem cells (hMSCs) induced towards chondrogenesis develop a pericellular matrix (PCM), rich in type VI collagen (ColVI) and proteoglycans such as decorin (DCN). Individual PCM protein functions still need to be elucidated to fully understand the mechanobiological role of this matrix. In this study we identified ColVI and DCN as important contributors in the mechanical function of the PCM and as biochemical modulators during chondrogenesis through targeted knockdown using shRNA lentiviral vectors. Gene expression, western blotting, immunofluorescence and cell deformation analysis were examined at 7, 14 and 28 days post chondrogenic induction. ColVI and DCN knockdown each affected gene expression of acan, bgn, and sox9 during chondrogenesis. ColVI was found to be of central importance in resisting applied strains, while DCN knockdown had strain dependent effects on deformation. We demonstrate that by using genetic engineering to control the biophysical microenvironment created by differentiating cells, it may be possible to guide cellular mechanotransduction.
Introduction
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine has the potential to repair damage in load bearing tissues such as articular cartilage (Alexopoulos et al., 2003; Guilak et al., 2006) , reducing the need for autologous chondrocytes. During chondrogenesis, hMSCs develop a pericellular matrix (PCM) that is rich in type VI collagen (ColVI) (Poole et al., 1992; Wiberg et al., 2003; Zhang et al., 2011) , fibronectin (Wiberg et al., 2003; DiMicco et al., 2007; Connelly et al., 2008) , hyaluronan (Knight et al., 1998; Zhang et al., 2011) , and proteoglycans (PGs) such as aggrecan, decorin (DCN), and biglycan (BGN) (Wiberg et al., 2003; Connelly et al., 2008) . This thin 2-6 µm layer of matrix acts as both a biomechanical buffer (Knight et al., 1998; Lee et al., 2010) , controlling the amount of deformation applied to the cell (Knight et al., 2001; Choi et al., 2007; Vigfusdottir et al., 2010) , as well as a biochemical conductor, presenting the cell with growth factors and signalling molecules (Chen et al., 2009; Vigfusdottir et al., 2010; Zhang et al., 2011) . The PCM is believed to modulate the mechanoresponsiveness of chondrocytes and chondrogenic hMSCs, but the exact roles of the individual PCM proteins has yet to be determined.
In articular cartilage, type VI collagen is found exclusively in the PCM surrounding chondrocytes (Poole et al., 1992; DiMicco et al., 2007) and is maintained through low levels of transcription, forming a microfibrillar network once secreted by the cell Poole et al., 1992; Wiberg et al., 2003; DiMicco et al., 2007; Vigfusdottir et al., 2010) . ColVI's interactions with the cell membrane at varying locations make it a primary candidate as a mechanotransducer (Poole et al., 1992; Doane et al., 1998; Loeser et al., 2000) . This complex network assembles and integrates with the surrounding extracellular matrix (ECM) through interactions with type II collagen, aggrecan, and hyaluronan with aid from PGs such as DCN, BGN, as well as type IX collagen Keene et al., 1988; Bidanset et al., 1992; Poole et al., 1992; Wiberg et al., 2003; Nareyeck et al., 2004; Connelly et al., 2008) .
The PCM has shown direct control over cellular phenotype, as chondrocytes isolated without a PCM exhibit a phenotypic change characterised by greater col1a1 and lower col2a1 expression than those isolated with a native PCM (Vonk et al., 2010) . The metabolic activity of hMSCs undergoing chondrogenic differentiation changes with PCM development and is also different from that of mature chondrocytes (DiMicco et al., 2007; Connelly et al., 2008) . Therefore, it is believed that the PCM directly surrounding chondrogenic hMSCs is temporally changing and complex, with the microenvironment composition influencing chondrogenic potential and response (Knight et al., 2001; DiMicco et al., 2007; Vonk et al., 2010) .
Biomechanically, the developing PCM surrounding both mature chondrocytes and differentiating hMSCs has been found to reduce cell deformation in hydrogels under applied compression (Knight et al., 1998; Lee et al., 2010; Vigfusdottir et al., 2010) . Protein deposition and biosynthesis progressively alter PCM material properties, causing increases in stiffness and elastic-like response (Lee et al., 2010) . The ability of the PCM to help articular chondrocytes resist deformation has been shown to depend on hyaluronan during initial PCM assembly, and speculated to depend on collagen and other matrix components at later time points (Knight et al., 1998) . Native chondrocytes with their PCM, which have been termed chondrons, exhibit a unique viscoelastic response to compression due to mismatched stiffnesses among the chondrocyte, its PCM, and the cartilage ECM (Guilak et al., 1999) .
Toward an improved understanding of how individual components of the PCM biochemically and biophysically regulate hMSCs during chondrogenesis, our current study sought to elucidate the roles of ColVI and DCN in resisting cellular deformation as well as their relationships with other PCM gene expression. We determined the function of these specific proteins through targeted subtraction using shRNAmediated RNA interference (RNAi) (Stewart et al., 2003) . Overall, we found that knockdown of ColVI and DCN differentially altered PCM accumulation, expression of other PCM components, and cell deformation in hydrogels. These results demonstrate that the microenvironment of chondrogenically differentiating hMSCs can be controlled using genetic engineering techniques to modulate PCM composition.
Materials and Methods

Cell culture
Passage 2 hMSCs were obtained from Lonza (Walkersville, MD, USA) and were expanded in monolayer according to the manufacturer's protocols, sub-culturing with growth media (GM): high glucose DMEM (HG-DMEM) (Gibco/ Invitrogen, Carlsbad, CA, USA) supplemented with 10 % foetal bovine serum (FBS) (Gibco), 100 U/mL penicillin/ streptomycin (Gibco), 1 % MEM non-essential amino acids (Gibco), and 4 mM L-Glutamine (Invitrogen). Cells were cultured in monolayer at 37 °C with 5 % CO 2 , with media changes three times per week until passage 4 or 5, at which point they were used experimentally. Experimental and control groups were lifted from monolayer with 0.25 % trypsin-EDTA (Gibco), centrifuged at 600 x g for 5 min before being re-suspended in a 2 % (w/v) alginate solution (Research Products International, Mount Prospect, IL, USA) at a concentration of 2.0 x 10 6 cells/mL. The cellalginate solution was expelled drop-wise into a 102 mM CaCl 2 bath using a 22 gauge needle and allowed to cure for 10 min. Alginate-hMSC beads were cultured in either GM or chondrogenic induction media (CM) containing HG-DMEM, ITS Universal Culture Supplement Premix (BD Biosciences, San Jose, CA, USA), 10 nM dexamethasone, 50 µg/mL L-ascorbic acid (Sigma-Aldrich, St. Louis, MO, USA), 40 µg/mL L-Proline (Sigma), 100 U/mL penicillin/streptomycin, 1 mM sodium pyruvate, 0.584 g/ mL L-glutamine, and 10 ng/mL TGF-β3 (Lonza). Beads were cultured for 1, 2, or 4 weeks post seeding at 37 °C with 5 % CO 2 .
Lentivirus preparation 21-23 nt shRNA sequences were designed using RNAi Codex (web ref. 1) from either human col6a1 [Gen Bank: NM_001848] or human dcn [GenBank: NM_001920] mRNA. Stem-loop-stem shRNA constructs were created, annealed to create complimentary oligos, and cloned into a lentiviral vector containing a blasticidin resistance gene with a U6 promoter and a Pol III termination sequence. The BLOCK-iT U6 RNAi Entry Vector Kit and the BLOCK-iT Lentiviral RNAi Expression System (Invitrogen, Carlsbad, CA) were used to generate shRNA constructs and packaged into a replication-deficient lentivirus (denoted shColVI A-E and shDcn A-F) using 293FT cells, Lipofectamine 2000 and a manufacturer-supplied packaging mix (Invitrogen). The chosen sequences are listed in Table 1 . A lentiviral expression vector containing the gene for GFP was prepared in parallel using the Vivid Colors pLenti6.2-GW/EmGFP kit (Invitrogen) for a lentiviral control. Virus-containing supernatants were harvested 72 h post transfection and stored at -80 °C until used experimentally.
shRNA transduction
For initial screening trials to identify optimal shRNA viral vectors, hMSCs were seeded at 60,000 cells/ well in tissue culture treated polystyrene 6-well plates. Monolayers of hMSCs were infected with lentiviral particles in the presence of 6 µg/mL Polybrene (Sigma) to aid in transduction efficiency. Each well was incubated with 100 µL of either an shColVI (A-E) or an shDcn (A-F) vector for 24 h. Cell monolayers were then washed and maintained in GM culture without selection for 1, 5, 8 or 14 days post infection, at which point gene expression was assessed.
In subsequent experiments, each well was incubated with either shColVI-D, shDcn-F (identified from our screen; hereafter labelled shColVI and shDcn, respectively), or the GFP control vector at a multiplicity of infection (MOI) of 1 for 24 h. Titered viral concentrations for an MOI of 1 were determined through a Quant-IT PicoGreen Assay (Invitrogen). After virus removal, cells were incubated with GM containing 12 µg/mL of blasticidin for 24 h, to select a pure population of transduced cells. We performed extensive preliminary sensitivity tests to identify this shorthigh intensity treatment for minimising adverse effects of blasticidin culture. Blasticidin-free shRNA-infected control and non-infected control hMSCs were cultured in parallel. Some hMSCs were cultured for 1, 4, 7 or 14 days post-infection for gene expression studies. Some blasticidin-selected pure populations were trypsinised for alginate bead culture 24 h post selection (day 0).
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Cell viability
To determine the viability of cells in alginate beads, at each time point per sample two or three beads were centrally cut and transferred to a working solution of 5-chloromethylfluorescein diacetate (CMFDA) and ethidium homodimer-1 (EthD-1) (Invitrogen) and counterstained with 4',6-diamidino-2-phenylindole (DAPI) (Invitrogen). From the cut face of the beads, ten confocal fluorescence image stacks of 30 µm depth were taken at 100x magnification with a Nipkow (spinning) disk-equipped Olympus IX81 microscope. Viability was assessed on sections using channel separation and threshold particle analysis using ImageJ (NIH). All results are expressed as a percentage of total cells that are viable (green only).
Gene expression
Gene expression was quantitatively assessed as previously described (Rastogi et al., 2009) . At each time point, cells (shColVI, shDcn, and GFP transduced, along with a noninfected hMSC control) were subsequently released with a 100 mM sodium citrate, 30 mM EDTA solution, spun down and re-suspended in a buffer solution containing β-Mercaptoethanol (Fisher Scientific, Pittsburgh, PA, USA) before flash freezing. Total RNA was isolated (RNeasy Micro, Qiagen, Valencia, CA, USA) and reverse transcribed. Gene expression was analysed using qRT-PCR (MyiQ System, BioRad, Hercules, CA, USA) with primers designed for human genes (Table 2 ) using Primer3 software (web ref.
2). All primer amplification efficiencies were determined using linear regression efficiency methods and were determined to be between 91.2 % and 108.2 % (R 2 > 0.99) (Rutledge and Cote, 2003) . Expression levels for acan, sox9, bgn, col6a1, col6a2, col6a3, dcn, col9a2 and housekeeping gene GAPDH were analysed using the ΔΔCt method. Threshold cycle (Ct) values were averaged and ΔCt was calculated by subtracting the average Ct values of GAPDH from those of the gene of interest (e.g. ΔCt col6a1 = Ct col6a1 -Ct GAPDH ). ΔΔCt for each gene of interest was determined by subtracting the designated 
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control ΔCt from the experimental ΔCt at each time point (e.g.
Relative gene expression levels (fold difference) were computed though the exponential relation 2 -ΔΔCt (Livak and Schmittgen, 2001) . Data are shown as average values of the range of calculated fold differences (2 -ΔΔCt +SD and 2 -ΔΔCt-SD ) ± range.
Western blotting
To quantify protein translation, cells were released from alginate as described above. Samples were re-suspended in a lysis buffer (50 mM HEPES (Fisher) , 150 mM sodium chloride (Fisher) , 1 % Triton X-100 (Ricca Chemical Compant, Arlington, TX, USA), 1 mM EDTA (Fisher), 10 mM Na-pyrophosphate (Fisher) , 10 % glycerine (Fisher)) with a 1:100 concentration of protease inhibitor cocktail (Fisher Scientific) to precipitate out the proteins.
A portion of the protein supernatant was separated for a modified Lowry assay to determine protein concentration using a Folin-Phenol colour reaction detected by a ND-1000 Spectrophotometer (Nanodrop, Wilmington, DE).
The remaining supernatant was mixed 1:1 with a loading buffer (13 % (v/v) Tris-HCl, 20 % (v/v) glycerol, 4.6 % (w/v) SDS, 0.02 % (w/v) bromophenol blue, 200 mM dithiothreitol). SDS-PAGE was performed using pre-cast Criterion Tris-HCl gels (BioRad) using equal amounts of protein from each sample. Proteins were detected with rabbit IgG antibodies targeting human β-actin (R-22; Santa Cruz Biotechnology, Dallas, TX, USA), α1(VI) (H-200; Santa Cruz), and decorin (H80; Santa Cruz). For decorin detection, blots were incubated with 1 U/mL chondroitinase ABC from Proteus vulgaris to digest dermatan-sulphate GAG chains from the decorin core protein (C2905, SigmaAldrich) for 3 h and washed with DPBS before blocking. Positive controls of CCD-1064Sk Cell Lysate (Santa Cruz) for β-actin and α1(VI), and 293 Lysate (Santa Cruz) for DCN were run simultaneously to ensure valid detection. Semi-quantitative analysis was performed using ImageJ to determine band intensities. Protein expression levels are shown relative to non-infected cells ± standard error of the mean (SEM). 
Immunofluorescence
Cellular deformation
For aspect ratio measurements under static compression, cells were isolated and re-embedded with their PCMs intact in new hydrogel constructs, to eliminate effects of changing alginate bead properties, as previously described (Vigfusdottir et al., 2010) . After cells were released from alginate using sodium citrate and EDTA, they were incubated with CMFDA to stain cell cytoplasm, 6-Carboxy-X-Rhodamine (6-ROX; Invitrogen) to stain non-specifically for the PCM and DAPI. Stained cells were then resuspended in 2 % (w/v) alginate and pipetted into a 6 mm x 6 mm x10 mm mould with a 10 µm porous membrane and Whatman thick blot paper (Biorad) paper attached to the top and bottom faces. The moulds were immersed in 102 mM CaCl 2 for 2 h to cure (Wang et al., 2011) . After curing, constructs were placed into a custom made micrometer-controlled deformation device (Vigfusdottir et al., 2010) and imaged at 0 %, 10 % and 20 % uni-axial bulk strain. Fluorescence images were acquired at 400x magnification. Major and minor cell diameters as well as the stained PCM (PCM+Cell) diameters were measured using Image J (NIH) and used to calculate aspect ratios (AR = minor cell diameter/ major cell diameter), as depicted in Fig. 1A . Representative images of PCM+Cell (non-infected), shColVI-transduced, and shDcn-transduced cells at 0, 10 and 20 % applied strain are shown in Fig. 1B . Normalised ARs (NAR) were calculated at each strain for each sample's population of average deformed AR compared to its un-deformed AR. Data are shown as NAR ±SEM.
Statistical analysis
Statistical analyses for cell viability, gene expression, western blotting and aspect ratios were performed using one-way ANOVA. Tukey's HSD post hoc tests were performed for pairwise comparisons. All computations were performed using JMP7 (Cary, NC) with statistical significance set to α < 0.05 or α < 0.01 as indicated in results.
Results
Lentiviral vectors can induce efficient shRNAmediated RNAi in hMSCs
Initial screening was conducted on hMSC monolayers to identify optimal shRNA constructs to use for subsequent experiments. Because each shRNA sequence was designed to target different locations along the mRNA strand, variation in knockdown due to mRNA folding was expected. We found that the shColVI D construct (n = 2) was most effective in knocking down col6a1 transcript levels, resulting in decreases of up to 45 % relative to non-infected hMSCs in monolayer over 14 d. Other constructs were less effective in inducing RNAi and were, therefore, excluded from subsequent experiments. Based on the screen, we performed experiments using blasticidin selection, to eliminate any non-transduced cells, and assessed gene silencing in hMSCs with shColVI D and shDcn F constructs (hereafter labelled shColVI and shDcn, respectively). The pure population of shColVI-transduced cells exhibited col6a1 expression that was significantly decreased by 67 % at day 4 (p < 0.01, n ≥ 2) and remained significantly depressed through 14 d (p < 0.01, n ≥ 2). Construct shDcn achieved a significant 89 % knockdown of dcn expression at day 1 and maintained this diminished level over the entire 14 d (p < 0.01 for all time points, n ≥ 2).
Gene silencing of PCM proteins does not affect chondrogenic differentiation
As in our previous studies (Vigfusdottir et al., 2010) , we used alginate bead culture of hMSCs in TGF-β3-supplemented chondrogenic induction media as a model system to study PCM formation during differentiation. To validate this approach for transduced cells, we verified knockdown of the target genes, quantified cell viability, and confirmed chondrogenic gene expression.
Significant target gene knockdown was achieved for both shRNA constructs, as assessed by qRT-PCR, relative to controls of non-infected hMSCs and of a lentivirus transduced GFP expression cassette ( Fig.   2A ). For shColVI-transduced cells, col61a1 knockdown remained statistically significant through 14 d but gradually diminished toward control levels by day 28 ( Fig. 2A. 2B and 2C ). Cells transduced with their respective silencing constructs produced less α1(VI) at day 7 and day 14, and less DCN at days 7 and 28.
To ensure viral treatment did not affect viability during the experiment, live-dead analysis was performed at 7, 14 and 28 d after hMSCs were embedded in alginate. Cells in all experimental groups maintained greater than 50 % viability through the 28 d. There was no significant difference between non-infected and infected cells; therefore, the viral transduction did not affect cell viability (data not shown).
To determine whether viral transduction or knockdown of col6a1 and dcn might disrupt chondrogenesis, we analysed acan and sox9 expression in non-infected and GFP-, shColVI-and shDcn-transduced cells. Previous work has shown that hMSCs cultured in alginate hydrogels in GM exhibit some features of chondrogenesis, with pericellular deposition of type VI collagen during the first 7 d of culture, but only with TGF-β3 supplementation 
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did chondrogenesis progress fully (Vigfusdottir et al., 2010) . Higher transcript levels were measured for both chondrogenic markers across all groups when cultured in CM at all time points relative to corresponding transduced cells cultured in GM (Fig. 3A and 3B ). Differences were statistically significant only at particular time points, likely due to fluctuating levels of gene expression during differentiation. There was no significant difference between non-infected controls and knockdown samples at any time point for sox9 expression. These data indicate that transduction with the silencing cassette did not affect the ability of hMSCs to undergo chondrogenic differentiation.
Knockdown of col6a1 and dcn alter PCM structure and gene regulation
The organisation of the pericellular matrix is temporally dependent on its composition. DCN is a primary modulator of ColVI network assembly as well as a connector to type II collagen and aggrecan (Bidanset et al., 1992; Nareyeck et al., 2004; Wiberg et al., 2003) . Targeted subtraction of ColVI and DCN were each expected to have direct impact on expression of pericellular proteins as well as PCM organisation during chondrogenesis.
ColVI and DCN deposition during chondrogenesis fully enveloped the non-infected and GFP-transduced cells ( Fig.  4A and 4B ). In non-and GFP-infected cells, DCN was visualised in concentrated pockets directly surrounding the cell membrane, with diffuse staining extending away from the cell mainly at day 7 and becoming more tightly gathered by day 28 (Fig. 4B as denoted by yellow arrows) . This is consistent with the notion that DCN binds proteins within the PCM to form a fully developed network, controlling protein spacing with its attached GAG chain.
Knocking down ColVI resulted in lower acan, bgn, and dcn levels during the first 14 d of chondrogenesis relative to non-infected and GFP-transduced cells (Fig. 3A, 5A and 5B). This difference was diminished by 28 d. Visualisation of DCN surrounding shColVI cells did not reflect the decreased transcription, showing similar fluorescence to control cells. Although ColVI knockdown affected dcn expression, DCN knockdown did not affect col6a1 levels (Fig. 5C ) but did alter its assembly. ColVI staining appeared to be membrane-bound and punctate, suggesting that DCN deficiency prevents ColVI from forming a continuous microfibrillar layer surrounding the cell (Fig.  4A as denoted by red arrows) . This punctate staining was 
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maintained over the course of the 28 d experiment. DCN knockdown also affected the expression of other PCM proteins, leading to increased levels of acan, bgn, and sox9 during the first two weeks. These results indicate that PCM gene expression is cross-regulated, with the greatest effects being in the first two weeks of chondrogenesis.
Cellular and PCM stiffnesses evolve during chondrogenic differentiation
In an effort to understand the mechanical role of the developing PCM during chondrogenesis, we employed an approach to quantify both the deformation of the cell itself (CM-hMSC) and the aggregate deformation of the cell with its PCM (PCM+Cell) over time in chondrogenic media (Fig. 6 ). Day 0 baseline controls represent hMSCs that had been embedded in alginate constructs directly from monolayer culture, and consequently had no exposure to chondrogenic media. At this time point, significant changes in normalised aspect ratios (NARs) were observed with applied strain. Note the nonlinear cell stiffness at day 0; cells deform greater from 0 to 10 % applied strain than from 10 to 20 %. At Day 7, GM cells (GM-hMSC) deformed less than Day 0 hMSCs, likely due to matrix production and assembly stimulated by 3D culture (Vigfusdottir et al., 2010) which is relatively stable between day 7 and day 14. Because there was no discernible PCM around GM cells, deformations were measured for cells only. For the CM group, incomplete elaboration of the PCM resulted in similar deformations between the cell (CM-hMSC) and the PCM+Cell.
At Day 14, GM cells exhibited significantly less deformation than at Day 7, but only at 10 % applied strain. For CM cells, the aggregate deformation of PCM+Cell was also correspondingly lower than at Day 7. The most striking change was in the PCM+Cell deformation, which was significantly lower at both 10 and 20 % applied strain. Interestingly, under 10 % strain, the change in NAR for CM cells was higher than that for the PCM+Cell, but these trends are reversed at 20 % applied strain (Fig.1B) . This suggests that the PCM is stiffer than the cell at 10 % applied strain, but that the cell becomes relatively stiffer than the PCM at 20 %.
ColVI and DCN are essential for resisting cellular deformation during compression
Our results above are consistent with previous research findings that during chondrogenesis hMSCs develop a mechanically functional PCM (Knight et al., 1998; Vigfusdottir et al., 2010) , and that changes in its stiffness affects cell deformation (Lee et al., 2010) . As a step toward elucidating the functional roles of specific PCM proteins, we examined cell deformations in genetically engineered CM-hMSCs. Again, for baseline measurements (Day 0), we seeded transduced and control cells into alginate discs, and immediately subjected them to compressive loading. Because of the universal lack of PCM, cells exhibited significant changes in normalised aspect ratios with each applied strain, with no significant differences between groups (Fig. 7A) . Similar nonlinearity in cell stiffness as observed in the previous experiment (Fig. 6 ) was found across all groups.
With culture, all conditions showed a greater resistance to the applied compression. However, the extent to which cell deformations decreased was dependent on treatment. Both non-infected CM-hMSCs and GFP controls exhibited the greatest decreases in cell deformation at both Day 7 and Day 14. This was expected since the PCM was allowed to develop normally in both groups. In addition, their similarity to each other confirms that the lentiviral infection of hMSCs does not affect cell stiffness.
ColVI deficient cells showed the greatest deformations across all groups at both Day 7 and Day 14, and for both magnitudes of applied strain (Fig. 7B and 7C) . Deformation was similar between Days 7 and 14, indicating that the Fig. 7 . Normalised aspect ratios of non-infected and GFP-, shColVI-, and shDcn-transduced hMSCs. Each condition was subjected to 0, 10 and 20 % applied strain at (A) day 0, (B) day 7, and (C) day 14. Graphs show normalised aspect ratios that are overlaid with progressively increasing strain increments (values are not cumulative) (*p < 0.05, **p < 0.01 significant difference from GFP-transduced cells at same nominal strain; # p < 0.05 significant deformation between 10 and 20 % applied nominal strain; n > 30). Data are shown as NAR ± SEM. ColVI and DCN in chondrogenic hMSC biophysics cell's inability to put in place a mechanical barrier does not change with time. Although direct comparisons cannot be made, we measured greater shColVI cell deformations than GM-hMSCs in previous experiments (Fig. 6) . Knocking down DCN resulted in interesting straindependent trends in cell deformation that were similar between Days 7 and 14 ( Fig. 7B and 7C) . At low levels of applied strain, cells deformed comparably with noninfected CM-hMSC and GFP controls, suggesting that the PCM was mechanically robust enough to sustain similar loads. However, once the applied strain reached 20 %, cellular resistance to deformation collapsed. We attribute this behaviour to the functional significance of decorin in mediating collagen-collagen interactions.
Overall, these results demonstrate that both ColVI and DCN have critical biophysical roles in regulating cell shape. In particular, ColVI is required for resisting even low magnitude strains, while DCN is important in maintaining structural integrity at higher strains.
Discussion
Stem cell therapies are currently being explored for their potential in the regeneration of load-bearing tissues, such as cartilage, due to both their pluripotency and their ability to maintain a basal phenotype during expansion in vitro. The PCM developed during chondrogenesis has been considered vital to the regulation of mechanotransduction events in differentiating hMSCs (Alexopoulos et al., 2003; Guilak et al., 2006; Villanueva et al., 2009; Vincent, 2013) . Reconstruction of the PCM in isolated mature chondrocytes has been shown to be complex, temporally specific in composition, and highly dependent on proteinprotein interactions within the PCM (Knight et al., 1998; Quinn et al., 2002; DiMicco et al., 2007) . Because chondrocyte function is closely tied to interactions with ECM proteins (Lee et al., 2000) , altering the constituents of the PCM would likely induce cascading effects on cellcell and cell-matrix interactions. PCM development in chondrogenic hMSCs is expected to be even more complex, due to the additional changes in gene regulation associated with differentiation. To elucidate the functional roles of individual components in the PCM, we investigated the consequences of knocking down col6a1 and dcn mRNA expression using shRNA lentiviral vectors.
Type VI collagen is a 125 nm long heterotrimer that consists of three different α-chains (α1(VI), α2(VI) and α3(VI)) and self-assembles into beaded filaments and larger fibrillar structures (Bruns et al., 1986) . ColVI trimer formation occurs intracellularly before being secreted into the PCM for microfibrillar networking via BGN or DCN (Bruns et al., 1986; Engvall et al., 1986; Wiberg et al., 2003; DiMicco et al., 2007) and is maintained at low levels of transcription (DiMicco et al., 2007; Vigfusdottir et al., 2010) . DCN is a ubiquitous proteoglycan, consisting of a core protein with a single chondroitin sulphate (Li et al., 2010) or dermatan sulphate (Knudson et al., 1996) side chain. It interacts with multiple collagens to create functional bridges between the PCM and surrounding ECM, and is involved in controlling fibrillogenesis and growth factor bioavailability (Chen et al., 2009; Lewis et al., 2010; Zhang et al., 2011) . This study shows that these two specific proteins, ColVI and DCN, have profound influence over PCM composition and biomechanical behaviour surrounding hMSCs undergoing chondrogenesis.
One of our major findings was the significant contributions of ColVI and DCN in cellular resistance to deformation. A developing PCM has been implicated in acting as both a biomechanical buffer (Knight et al., 1998; Vigfusdottir et al., 2010; Appelman et al., 2011) as well as a biochemical bridge (Guilak et al., 2006; Villanueva et al., 2009; Vincent, 2013) . Acting as a biomechanical buffer, the PCM shields the cell from deformation which could be potentially detrimental while also enhancing small tissue strains for stimulation (Alexopoulos et al., 2005; Choi et al., 2007; Vigfusdottir et al., 2010) . Previous studies analysing deformation properties of chondrocytes in alginate hydrogels have shown that cells under compression form oblate spheroids with a decrease in cell diameter along the axis of loading and an increase in transverse cell diameters perpendicular to that axis (Knight et al., 2002) . During initial matrix deposition, we found that the matrix and cell share similar deformations, due to the lack of full matrix envelopment. As the matrix stiffens to approach and then surpass cellular stiffness, the mechanical properties are contributed to more equally by both components (Lee et al., 2010) . With a fully developed matrix, at higher strains the PCM+Cell would reorganise due to hydration changes and spatial consolidation of collagen. Studies examining the PCM surrounding mechanically isolated chondrons are consistent with an initial elastic response followed by a transiently changing flow-dependent creep response under applied stress (Alexopoulos et al., 2005; Alexopoulos et al., 2009) . The mechanical behaviour is dependent on PCM structure, with the elastic response governed by matrix Normalised AR values of each deformation and condition. (p < 0.05 and p < 0.01 with respect to increasing symbols. #: from Day 7 same strain, ‡: from D0 same strain. n > 30).
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deposition (Lee et al., 2010) that is highly associated with sGAG and collagen accumulation (Knight et al., 1998) , and the viscous response governed by the osmotic and porous properties of the PCM network (McLane et al., 2013) . By altering the presence of ColVI and DCN, we sought to determine their involvement in this composition dependent mechanical response. In mature articular chondrocytes, the PCM has a higher modulus than that of the cell (Guilak et al., 1999) . Previous studies in ColVInull mice demonstrate that a PCM can be formed, but that ColVI-null chondrons have significantly reduced stiffness compared to wild-type chondrons (Alexopoulos et al., 2009) . The lowered resistance to deformation we observed in ColVI knockdown cells during chondrogenic PCM development is consistent with this reduced stiffness. ColVI can therefore be considered the primary protein involved in buffering loads to differentiating hMSCs.
During PCM development, it has been seen that sGAGs are important in the initial stages of assembly, directly impacting cellular mechanical responses to load (Knight et al., 1998) . PGs mediate the PCM to ECM interface through interactions with types II and VI collagen (Bidanset et al., 1992; Wiberg et al., 2003; Connelly et al., 2008; Chen et al., 2009) . Cells compensated for dcn knockdown by upregulating bgn expression, demonstrating a regulatory effect by DCN on other PCM small leucine rich PGs (sLRPs) (Ferdous et al., 2007) . BGN core protein has significant sequence homology with that of DCN, but is structurally distinct and possesses two (instead of one) CS/DS chains (Fisher et al., 1989; Neame et al., 1989; Krishnan et al., 1999) . Similar compensatory effects have also been seen in DCN knockout models (Chen et al., 2009; Lewis et al., 2010) . BGN shares binding sites on collagen proteins with DCN. However, its lower affinity for these binding sites results in less involvement in PCM and ECM organisation (Chen et al., 2009) , and its extra CS/DS-side chain results in a looser collagen network (Bidanset et al., 1992; Wiberg et al., 2001; Nareyeck et al., 2004; Ferdous et al., 2007; Lewis et al., 2010) . The looser collagen spacing possibly contributed to the significant increases in shDcn cellular deformation at higher strains. This network is bound to the cell membrane through HA core protein-CD44 interactions (Knudson et al., 1996) , NG2 receptors (membrane bound chondroitin sulphate PGs) or through direct binding to the α1β1 integrin (Loeser et al., 2000) . From our confocal images, the altered ColVI assembly in shDcn knockdown cells appeared as punctate localisations completely surrounding the cells at these binding sites.
In addition to acting as a mechanical stabiliser, the PCM also aids maintenance of chondrocyte phenotype biochemically. Our data are in agreement with chondrogenic stage specific gene expression (Xu et al., 2008) , with col6a1 being significantly greater in the first seven days of chondrogenesis in non-infected and GFP-transduced cells, which decreases in expression by 28 d of culture. DCN is involved in the sequestration of TGF-β3, FGF-2, TNF-α, PDGF, and IGF-1 (Ferdous et al., 2007; Chen et al., 2009; Zhang et al., 2011) and has been associated with cell proliferation signalling (Chen et al., 2009) , causing the cell to cease proliferation and enhance matrix synthesis.
These growth factors cause PCM accumulation during chondrogenesis in a concentration dependent manner (Mehlhorn et al., 2006; Lee et al., 2010; Li et al., 2010) . Sequestration of growth factors immediately surrounding the cell allows for specifically stimulated responses, being released mechanically or enzymatically from their associated PG for presentation to the cell membrane. Sox9, comp and HAPLN1 expression levels have shown to reach a peak by 12 d of culture associated with high levels of matrix assembly and metabolism (Xu et al., 2008) . The transient overexpression of sox9 in shDcn cells at day 14 could be due to the lack of regulation and continuous bioavailability of TGF-β3 to the cell.
Full PCM formation occurs within the first two weeks of TGF-β3 stimulation in vitro, which parallels the upregulation of acan and bgn expression during the first 14 d, and then steadily matures as acan returns to control levels. PCM retention has been shown to be mediated through interactions between CD44 and hyaluronic acid, which lay a foundation for aggrecan accumulation and affects PCM volume and shape (Alexopoulos et al., 2005; Knudson et al., 1996) . Hyaluronan is critical for maintenance of the pericellular environment surrounding chondrocytes (Lee et al., 2000) , interacting with type II collagen, aggrecan and link protein. The observed higher acan upregulation in shDcn cells could aid in matrix protein retention and reorganisation, causing large changes in the mechanical composition of the PCM, affecting cellular metabolism. shColVI cells showed an opposite trend of acan and bgn expression, with lower expression levels during the first 14 d of culture than all other samples.
Conclusion
To our knowledge, this study is the first to elucidate the functional significance of DCN in the PCM. Furthermore, we extend our previous work (Vigfusdottir et al., 2010) by demonstrating that ColVI is crucial for the biomechanical integrity of the PCM in chondrogenic hMSCs at all stages of differentiation. The use of shRNA expressing lentiviral vectors allows stable production of siRNAs by the cell . This approach has enabled us to characterise how specific PCM proteins govern the micromechanical environment of differentiating hMSCs over time. Although further studies are required to elucidate the downstream effects on mechanotransduction events, signalling cascades, and load-induced behaviours, our results provide some immediate insight into strategies that can be used to engineer specific microenvironments for eliciting desired cellular responses.
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ColVI and DCN in chondrogenic hMSC biophysics (Engler et al., 2006; Haudenschild et al., 2009, additional references) . With ColVI knockdown, the inability for hMSCs to form a mechanically robust PCM results in greater degrees of distortional strain under compressive loading. We would expect these cells to exhibit impaired chondrogenic differentiation and enhanced fibrogenic/ osteogenic potential. Knocking down DCN would likely yield strain-dependent effects, since the ability for the PCM to attenuate cell deformation is lost at higher loads. Therefore, within a single construct, transduced and nontransduced cells would be able to respond differently, even while the construct is stimulated under uniform biochemical and biomechanical conditions. F o r c h o n d r o g e n i c p r o g e n i t o r s , c h a n g i n g the cell's resistance to loading will cause a shift in mechanotransduction events, possibly initiating a more catabolic response or a more osteoarthritic phenotype. In either case, the mechanobiology of engineered hMSC differentiation would have to be experimentally investigated, because of the interacting factors that mediate cell deformation, and the complex pathways that regulate differentiation. Current studies show that chemically altering the cytoskeleton can tilt the mechanoresponse of stem cells between chondrogenic versus hypertrophic differentiation (Guilak, 1995; Farquharson et al., 1999; Kumar and Lassar, 2009, additional references) . Cytoskeletal alterations could also be indirectly achieved through ColVI and DCN knockdown, caused by changes in PCM-cell membrane interactions, though this also needs to be further explored. The composition of the PCM also has a bearing on the bioavailability of growth factors, which would further influence differentiation. DCN's ability to sequester TGF-β within t)he PCM (Ferdous et al., 2007, text reference), for example, may control whether or not the stem cell's differentiation response is robust. Our study found that knocking down DCN resulted in a high upregulation of sox9 at day 14, which could indicate a temporal shift in terminal differentiation.
By targeted subtraction of ColVI and DCN, we can modify the cell's mechanobiological response either by controlling the ability of the cell to resist compression or by accelerating lineage-and stage-specific gene expression. Intrinsically regulating the cell's microenvironment allows the study of how these specific proteins are involved in short and long term mechanotransduction events that has yet to be achieved.
